NOT FOR DISTRIBUTION
Header cover image

Jilin Zixin Pharmaceutical IndustrialLtd

Market Cap

CN¥4.0b

Last Updated

2021/04/11 09:06 UTC

Data Sources

Company Financials

Executive Summary

Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines, gene sequencers, and supporting reagents in China. More Details


Snowflake Analysis

Mediocre balance sheet and overvalued.

Share Price & News

How has Jilin Zixin Pharmaceutical IndustrialLtd's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 002118 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 002118's weekly volatility (8%) has been stable over the past year.


Market Performance


7 Day Return

1.3%

2118

-0.1%

CN Pharmaceuticals

-1.1%

CN Market


1 Year Return

-43.8%

2118

15.8%

CN Pharmaceuticals

28.4%

CN Market

Return vs Industry: 002118 underperformed the CN Pharmaceuticals industry which returned 15.8% over the past year.

Return vs Market: 002118 underperformed the CN Market which returned 28.4% over the past year.


Shareholder returns

2118IndustryMarket
7 Day1.3%-0.1%-1.1%
30 Day-1.9%3.9%1.0%
90 Day13.5%-5.4%-5.8%
1 Year-43.8%-43.8%16.9%15.8%30.4%28.4%
3 Year-65.7%-65.7%25.2%20.7%25.9%19.9%
5 Year-59.6%-59.6%41.6%34.1%23.6%15.5%

Long-Term Price Volatility Vs. Market

How volatile is Jilin Zixin Pharmaceutical IndustrialLtd's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Jilin Zixin Pharmaceutical IndustrialLtd undervalued compared to its fair value and its price relative to the market?

0.96x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: 002118 (CN¥3.11) is trading above our estimate of fair value (CN¥1.85)

Significantly Below Fair Value: 002118 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 002118 is unprofitable, so we can't compare its PE Ratio to the CN Pharmaceuticals industry average.

PE vs Market: 002118 is unprofitable, so we can't compare its PE Ratio to the CN market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 002118's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 002118 is good value based on its PB Ratio (1x) compared to the CN Pharmaceuticals industry average (2.7x).


Future Growth

How is Jilin Zixin Pharmaceutical IndustrialLtd forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

24.3%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jilin Zixin Pharmaceutical IndustrialLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Jilin Zixin Pharmaceutical IndustrialLtd performed over the past 5 years?

-40.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 002118 is currently unprofitable.

Growing Profit Margin: 002118 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 002118 is unprofitable, and losses have increased over the past 5 years at a rate of 40.7% per year.

Accelerating Growth: Unable to compare 002118's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 002118 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (10.8%).


Return on Equity

High ROE: 002118 has a negative Return on Equity (-15.68%), as it is currently unprofitable.


Financial Health

How is Jilin Zixin Pharmaceutical IndustrialLtd's financial position?


Financial Position Analysis

Short Term Liabilities: 002118's short term assets (CN¥8.3B) exceed its short term liabilities (CN¥5.1B).

Long Term Liabilities: 002118's short term assets (CN¥8.3B) exceed its long term liabilities (CN¥1.4B).


Debt to Equity History and Analysis

Debt Level: 002118's debt to equity ratio (128.9%) is considered high.

Reducing Debt: 002118's debt to equity ratio has reduced from 134.4% to 128.9% over the past 5 years.

Debt Coverage: 002118's debt is not well covered by operating cash flow (3.9%).

Interest Coverage: Insufficient data to determine if 002118's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Jilin Zixin Pharmaceutical IndustrialLtd current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 002118's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 002118's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 002118's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 002118's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 002118 is not paying a notable dividend for the CN market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 002118's dividend in 3 years as they are not forecast to pay a notable one for the CN market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average board tenure


CEO

Jilin Zixin Pharmaceutical IndustrialLtd has no CEO, or we have no data on them.


Board Members

Experienced Board: 002118's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Jilin Zixin Pharmaceutical Industrial Co.,Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Jilin Zixin Pharmaceutical Industrial Co.,Ltd.
  • Ticker: 2118
  • Exchange: SZSE
  • Founded: 1998
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CN¥3.983b
  • Shares outstanding: 1.28b
  • Website: https://www.jilinzixin.com.cn

Number of Employees


Location

  • Jilin Zixin Pharmaceutical Industrial Co.,Ltd.
  • No. 137, Dongtoudao Street
  • Nanguan District
  • Changchun
  • Jilin Province
  • 130041
  • China

Listings


Biography

Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines, gene sequencers, and supporting reagents in China. It provides ginseng products; prescription prod...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/11 09:06
End of Day Share Price2021/04/09 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.